Understanding Your Cancer Diagnosis

Reading your pathology report

A pathology report describes what the laboratory saw under the microscope after a biopsy or surgery. It typically names the tissue, the cancer type (e.g., "invasive ductal carcinoma"), the grade (how abnormal the cells look), and any molecular markers that were tested.

Ask your oncologist to walk through your report line by line at your first visit. Most cancer centers will give you a copy — keep it and bring it to second opinions.

Cancer stage and grade

Stage describes how far the cancer has spread. Most solid tumors use the TNM system: T (size or extent of the primary tumor), N (whether nearby lymph nodes are involved), and M (whether the cancer has spread to distant organs). These combine into a stage from I to IV.

Grade describes how abnormal the cells look — low grade cells resemble normal tissue and tend to grow slowly; high grade cells look very different and tend to grow faster. Stage and grade together drive prognosis and treatment intensity.

How treatment plans are built

Modern cancer care is rarely a single doctor making a decision alone. Most cases are reviewed at a "tumor board" where surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists discuss the case together and agree on a recommended approach.

Treatment options are matched to your cancer type, stage, biomarkers, overall health, and your goals. For many cancers there are multiple reasonable approaches — ask your oncologist what other options the tumor board discussed and why they recommend the one they chose.

Common questions

Should I get a second opinion?

For most cancers, yes — especially for rare cancers, complex cases, or before any major surgery. Second opinions rarely change the diagnosis but often refine the treatment plan, and most oncologists encourage them.

How fast do I need to start treatment?

A few weeks to plan carefully almost never changes outcomes for most cancers. Acute leukemias and aggressive lymphomas are exceptions — your team will tell you if your case is time-sensitive.

What does "biomarker testing" mean and do I need it?

Biomarker (or molecular) testing looks at specific genes, proteins, or mutations in your tumor that can guide targeted therapy or immunotherapy choices. For many modern cancers it is now standard before starting treatment — ask your oncologist what testing was done on your sample.